J 2002

Polymorphism NcoI in tumor necrosis factor b is associated with fasting glycemia and lipid parameters in healthy non-obese Caucasian subjects: Preliminary report

KAŇKOVÁ, Kateřina; Ivana MÁROVÁ; Eugene HJM JANSEN; Anna VAŠKŮ; Michal JURAJDA et al.

Základní údaje

Originální název

Polymorphism NcoI in tumor necrosis factor b is associated with fasting glycemia and lipid parameters in healthy non-obese Caucasian subjects: Preliminary report

Název česky

Polymorfizmus NcoI v genu pro tumornekrotizujici faktor b je asociovan s glykemii nalacno a lipidovymi parametry u zdravych neobeznich osob: predbezne vysledky

Autoři

KAŇKOVÁ, Kateřina; Ivana MÁROVÁ; Eugene HJM JANSEN; Anna VAŠKŮ; Michal JURAJDA ORCID a Jiří VÁCHA

Vydání

Diabetes & Metabolism, Francie, Editions Masson, 2002, 0338-1684

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30202 Endocrinology and metabolism

Stát vydavatele

Francie

Utajení

není předmětem státního či obchodního tajemství

Impakt faktor

Impact factor: 1.546 v roce 2001

Označené pro přenos do RIV

Ano

Kód RIV

RIV/00216224:14110/02:00005552

Organizační jednotka

Lékařská fakulta

Klíčová slova anglicky

Type 2 diabetes mellitus; TNF-b polymorphism; insulin resistance; glycemia; glucose intolerance
Změněno: 18. 6. 2009 09:51, prof. MUDr. Anna Vašků, CSc.

Anotace

V originále

Background: The study was designed to investigate the associations among polymorphisms TNF-b NcoI and TNF-a -308G/A, plasma TNF-a levels and metabolic and anthropometric parameters related to insulin sensitivity in a set of 113 Caucasian subjects undergoing oral glucose tolerance test (oGTT). Methods: Genotypes were detected by PCR; BMI, WHR, glycemia during oGTT, fasting immunoreactive insulin, fasting C-peptide, HbA1c, total cholesterol, triglycerides, HDL, LDL and plasma TNF-a levels were measured in each subject. Results: Type 2 diabetes was diagnosed in 10 subjects, impaired glucose tolerance (IGT) in 41, normal glucose tolerance (NGT) in 62. Significant differences among genotypes of the TNF-b NcoI were observed for FPG (P=0.0063), LDL (P=0.0179) and marginally for total cholesterol (P=0.0763) in NGT group. After the classification of NGT subjects into obese and non-obese according to BMI, associations of TNF-b NcoI with FPG, LDL and cholesterol were proved in non-obese subgroup only. TNF-a -308G/A polymorphism was not associated with any of the parameters studied. TNF-a levels did not revealed difference among NGT, IGT and DM groups or genotype-dependent differences. Conclusions: Our results indicate significant association of the TNF-b NcoI polymorphism with FPG, LDL and total cholesterol in normoglycemic non-obese Caucasian subjects. This polymorphism could be involved in genetic modulation of glucose and lipid homeostasis and regulation of insulin sensitivity already in healthy state. Disturbances of this regulation could be component of pathogenesis of type 2 diabetes mellitus.

Česky

Zjistili jsme, ze polymorfizmus NcoI v genu pro tumornekrotizujici faktor b je asociovan s glykemii nalacno a lipidovymi parametry (LDL a cholesterol) u zdravych neobeznich osob.

Návaznosti

MSM 141100002, záměr
Název: Molekulární patofyziologie multigenních chorob
Investor: Ministerstvo školství, mládeže a tělovýchovy ČR, Molekulární patofyziologie multigenních chorob